Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anaerobic microbial nitroreductive enzymes and low-potential redox proteins constitute a specialized electron transport system essential for the survival of anaerobic and microaerophilic bacteria and protozoa. This system primarily includes nitroreductases (NTRs), which are flavin-containing enzymes, and low-potential electron carriers such as ferredoxins and flavodoxins (PMID: 15105405). These components are critical for anaerobic metabolic processes, such as the decarboxylation of pyruvate via the pyruvate:ferredoxin oxidoreductase (PFOR) pathway, which operates at a very low redox potential (PMID: 10490597). In clinical medicine, this system is the primary target for nitroimidazole and nitrofuran antibiotics. These drugs function as prodrugs that are selectively reduced by the microbial electron transport chain, generating highly reactive nitro radical intermediates (PubChem CID 4168). These intermediates cause lethal damage to microbial DNA and proteins, while mammalian cells remain largely unaffected due to their higher oxygen tension and lack of similar low-potential redox pathways (StatPearls: Metronidazole). This target system is vital for treating infections caused by pathogens such as Clostridioides difficile, Helicobacter pylori, and various anaerobic protozoa.
Reductive activation of nitro-containing prodrugs into reactive radical intermediates (such as nitroso and hydroxylamine derivatives) that cause oxidative damage to DNA, leading to strand breaks and inhibition of nucleic acid synthesis (PMID: 15105405, PubChem).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anaerobic microbial nitroreductive enzymes and low-potential redox proteins (NTR/LPRP).